Search for: "Ely v. Ely" Results 101 - 120 of 1,844
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2009, 9:43 pm
Seeking approval to manufacture and market a generic version of Plaintiff-Appellee Eli Lilly and Company's raloxifene hydrochloride formulation, which Lilly markets as Evista ® for the treatment and prevention of postmenopausal osteoporosis, Teva filed an ANDA with the FDA in 2006. [read post]
29 Aug 2016, 2:17 am by Aida Tohala
The issues in this case were remitted by the Court of Appeal in its June 2015 decision overturning the grant of DNIs regarding the same European Patent, which was based on reconstitution of Actavis’ pemetrexed product in saline (Actavis UK Limited v Eli Lilly & Company [2015] EWCA Civ 555). [read post]
18 Oct 2011, 1:47 pm
Oral Argument in case# 10-3855; Susan Schaefer-LaRos v. [read post]
16 Aug 2015, 9:03 pm by Patent Docs
Eli Lilly and Company et al. v. [read post]
14 Dec 2009, 9:59 pm
Eli Lilly & Co. last week, Chief Judge Michel asked Lilly's counsel whether Lilly had preserved the written description issue by timely objecting to District Court Judge Zobel's jury instruction (see "Ariad v. [read post]
2 Nov 2011, 12:57 pm
Still, you can’t blame the inventor for trying… The dispute in Human Genome Sciences v Eli Lilly is, by comparison, a whole other kettle of fish. [read post]
20 Oct 2022, 6:30 am by Guest Blogger
 Ely had an important big idea—that judicial review (in a case like Brown v. [read post]
15 Jan 2015, 9:00 am by Diana A. Silva
The case is pending in the Middle District of Pennslyvania, captioned as Ely et al. v. [read post]